Chimeric antigen receptor (CAR) T, targeting SLAMF7 (CS1) or the B cell maturation antigen (BCMA) can efficiently eliminate MM cells in vitro [4, 5, 6]. Here, TNFRSF17 is linked to Miyoshi myopathy.